Table 2.
COVID-19 vaccine characteristics
| Vaccine | WHO EUL holder | Doses/vial | Shelf-life | Storage |
|
COMIRNATY COVD-19 mRNA vaccine (nucleoside modified) |
BioNTech Manufacturing GmbH |
6 | 9 months after date of manufacture for undiluted vaccine at storage temperature −90°C to −60°C |
|
|
VAXZEVRIA COVID-19 vaccine (ChAdOx1-S (recombinant)) |
AstraZeneca AB/SK Bioscience Co. Ltd AstraZeneca AB |
10 | 6 months for unopened vials stored at 2–8°C |
|
|
COVISHIELD COVID-19 vaccine (ChAdOx1-S (recombinant)) |
Serum Institute of India Pvt. Ltd | 10 | Unopened vials can be stored at 2–8°C for 6 months or up to 25°C for 2 hours Opened vials can be stored at 2–25°C for use within 6 hours |
|
| COVID-19 vaccine (Ad26.COV2-S (recombinant)) | Janssen–Cilag International NV | 5 | Unopened vials −25°C to 15°C for 2 years Unopened vials 2–8°C for 4.5 months of printed expiration date Up to 25°C for 2 hours |
|
|
SPIKEVAX COVID-19 mRNA vaccine (nucleoside modified) |
Moderna Biotech ModernaTX, Inc |
10, 15 | 9 months at storage temperature: 20°C±5°C |
|
| Inactivated COVID-19 Vaccine (Vero Cell) | Beijing Institute of Biological Products Co., Ltd. (BIBP) | 1, 2 or 5 | 24 months |
|
|
CoronaVac COVID-19 vaccine (Vero Cell), inactivated |
Sinovac Life Sciences Co., Ltd | 1, 2 and PFS | 12 months |
|
|
COVAXIN COVID-19 vaccine (whole virion inactivated corona virus vaccine) |
Bharat Biotech International Ltd | 1, 5, 10, 20 | 9 months |
|
|
COVOVAX COVID-19 vaccine (SARS-CoV-2 rS protein nanoparticle (recombinant)) |
Serum Institute of India Pvt. Ltd | 1, 10 | 9 months |
|
|
NUVAXOVID COVID-19 vaccine (SARS-CoV-2 rS (recombinant, adjuvanted)) |
Novavax CZ a.s | 10 | 9 months |
|
EUL, Emergency use listing procedure; PFS, Prefilled syringe vaccine doses; ULT, Ultra low temperature.